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1148 Abstracts October 2013perhaps suggesting an incomplete SMC differentiation in some cell lines.
ASC-SMC demonstrated a 12% increase in contraction when plated onto
a collagen gel (P ¼ .04). Cells seeded onto the SIS scaffold and ﬂow condi-
tioned for 5 days exhibited extensive cellular retention and orientation in the
direction of ﬂow on both the abluminal and luminal surfaces (Fig).
Conclusions: These data demonstrate (1) the potential of autologous
ASC to acquire SMC characteristics (molecular markers, contraction) in
response to growth factor stimulation; and (2) the creation of a multilayered,
tissue-engineered vascular graft from a single, autologous adult stem cell
source. In vivo investigation of the graft within a canine model to evaluate
the addition of the medial layer is underway.
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Objectives: Central vein stenosis or occlusion remains an unfortunate
complication associated with the use of dialysis catheters. The risk is not trivial
as nearly 80% of patients commence therapy via a central venous catheter. In
patients with a functioning arteriovenous ﬁstula, central vein stenosis can lead
to debilitating arm, and breast and/or neck swelling. Treatment typically
involves central vein angioplasty and/or stenting, but restenosis and reocclu-
sion rates remain high. Presented here are the initial results of a unique series
of patients with a mature arteriovenous access and symptomatic upper
extremity venous hypertension who, after having failed endovascular therapy,
were treated with axillary vein to femoral vein bypass.
Methods: This is a retrospective analysis of seven hemodialysis patients
with functioning right upper extremity access who underwent axillary vein to
femoral vein bypass between December 2011 and January 2013. Indications
for venous bypass included upper extremity swelling in ﬁve of the patients and
a combination of breast and upper extremity swelling in two of the patients.
Results: The median age was 60 years (range, 42-82) and ﬁve of seven
patients were male. The etiology of end-stage renal disease (ESRD) included
hypertension (2), diabetes (2), lupus nephritis (2), and focal segmental glo-
merulosclerosis (1). At least ﬁve of the patients had documentation of prior
central venous catheter placement and all seven underwent a previous endo-
vascular procedure, which was either unsuccessful or technically unfeasible.
Ringed polytetraﬂuoroethylene was used in all seven cases and the average
hospital stay was 1.8 days (range, 1-3). All seven patients experienced resolu-
tion of their swelling, and there have been no major graft complications.
Conclusions: Axillofemoral venous bypass is a safe and effective treat-
ment option for the dialysis patient with symptomatic venous hypertension
due to central vein occlusion.
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Objectives: Hemodialysis vascular access (HVA) salvage after acute
thrombosis raises a debate between nephrologists and vascular surgeons
regarding the urgency of treatment. To assess the impact of early surgical
thrombectomy on the rate of HVA salvage, we offered an early surgical
protocol to eligible patients with acute HVA thrombosis.
Methods: Between January 2007 and October 2012, a total of 114
surgical thrombectomy attempts were performed on 82 patients to salvage
89 HVA. Time between the diagnosis of thrombosis and the admission inthe operation suite (T1), time between the diagnosis and the following dialysis
session (T2), and clinical and biological parameters were collected prospec-
tively for retrospective analysis. The main outcome measure was technical
success. Kaplan-Meier survival analysis estimated functional patency rates.
Results: Mean duration T1 was 5 hours 42 minutes (64 hours 24
minutes).Overall technical success ratewas 81% (92/114). A short-term cath-
eterwas placed following20 technical failures (18%).MeandurationT2was17
hours 18minutes (68 hours 48minutes). Early thrombectomywithin 6 hours
after diagnosis had a signiﬁcantly higher technical success rate (86%) compared
with thrombectomyperformed$6hours (69%;OR, 2.96; 95%CI, 1.10-7.97;
P¼ .03, logistic regression). Previous thrombosiswas also associatedwith tech-
nical failure (OR, 0.32; 95% CI, 0.12-0.86; P ¼ .02), whereas type of graft
(autologous/prosthetic) was not (P ¼ .89). The 30-day mortality rate was
2% (2/114). Mean patient follow-up was 22 6 18 months. Primary patency
rates were 56%6 7% and 41%6 7% at 1 and 2 years, respectively. Secondary
patency rates were 74% 6 7% and 56% 6 7% at 1 and 2 years, respectively.
Autologous ﬁstulae had higher secondary patency rates compared with pros-
thetic grafts (HR, 0.38; 95% CI, 0.18-0.82; P ¼ .01, Cox model).
Conclusions: With early surgical thrombectomy, there are increased
rates of HVA salvage that predict less reliance on catheter usage for
hemodialysis.
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Objectives: Initiation of dialysis therapy using autologous access is
crucial for establishing successful long-term dialysis therapy. The lead time
that is required for construction of the fully functional dialysis access prior
to dialysis is currently unknown. We have proposed to establish a lead
time algorithm for ﬁstula creation to be used based upon the anatomic loca-
tion of the ﬁstula as well as the type of conduit.
Methods: We reviewed the data for dialysis access creation over a 1-
year period in an inner city hospital. All patients prior to access placement
underwent arterial physiologic testing, arterial measurement, and venous
mapping. Criteria for use of venous conduits required vein diameters greater
than 2.5 mm. Arterial use was based upon a greater than 2-mm diameter as
well as appropriate physiologic parameters include extremity, hand, and
digital pressure measurements with and without radial and ulnar compres-
sion testing. A maturation algorithm was created, which was based upon
anatomic locations and essential preoperative factors.
Results: Over a 1-year period, 103 access procedures were performed.
There was a 60% rate for primary ﬁstula creation. Fifteen radiocephalic, 26
basilic vein transpositions, and 20 brachiocephalic primary access procedures
were performed, the rest were brachio-axillary grafts. Over this period, seven
accesses failed, three were lost to follow-up, and one patient died. The
average maturation time for all access procedures was 5.3 weeks. The
longest time to maturation involved the radiocephalic ﬁstula group, and
this required 10.3 weeks. Brachiocephalic ﬁstula maturation occurred an
8.6 weeks, and basilic vein transposition in 6.7 weeks. Prosthetic grafts
required 2.9 weeks until they were usable.
Conclusions: Based upon these results, we established the following
algorithm. All patients that reached chronic kidney disease stage IV that
were referred for access creation immediately underwent arterial and venous
ultrasound. Based upon vein suitability, patients were stratiﬁed into four
groups. Primary radiocephalic ﬁstula requires the longest time for full matu-
ration and suitability for use, followed by brachiocephalic and basilic vein
transposition. We, therefore, recommend patient referral to access centers
at least 6 months prior to anticipated dialysis requirement if we are to main-
tain the highest standards that have been established for the creation of
primary/autogenous arteriovenous ﬁstulas in this patient population.
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Objectives: The National Kidney Foundation-Dialysis Outcomes
Quality Initiative recommends the preferential creation of arteriovenous
ﬁstulas (AVF) for hemodialysis access. Achieving and maintaining functional
patency of preferred hemodialysis access is a challenge for vascular surgeons
and a large healthcare expense. We sought to explore age-related and
gender-related differences in the costs of creating and of maintaining radio-
cephalic (RCF), brachiocephalic (BCF), and brachiobasilic (BBF) AVFs.
Methods: A prospectively maintained institutional database identiﬁed
348 patients undergoing access creation between 2004 and 2011 with 2
years of documented functional patency from the date of creation. Medical
records were analyzed for central venous catheter events, access-related
